INO logo

INO
Inovio Pharmaceuticals Inc

92,437
Mkt Cap
$154.58M
Volume
1.05M
52W High
$2.98
52W Low
$1.30
PE Ratio
-0.87
INO Fundamentals
Price
$2.16
Prev Close
$2.25
Open
$2.20
50D MA
$2.18
Beta
1.30
Avg. Volume
1.37M
EPS (Annual)
-$3.95
P/B
-15.61
Rev/Employee
$1,625.05
Loading...
Loading...
News
all
press releases
INOVIO Reports Inducement Grant Under Inducement Plan
INOVIO Reports Inducement Grant Under Inducement Plan INOVIO Reports Inducement Grant Under Inducement Plan PR Newswire PLYMOUTH MEETING, Pa., Dec. 19, 2025 PLYMOUTH MEETING, Pa., Dec. 19, 2025...
PR Newswire·4d ago
News Placeholder
More News
News Placeholder
INOVIO to Participate in December Investor Conferences
INOVIO to Participate in December Investor Conferences INOVIO to Participate in December Investor Conferences PR Newswire PLYMOUTH MEETING, Pa., Nov. 18, 2025 PLYMOUTH MEETING, Pa., Nov. 18, 2025...
PR Newswire·1mo ago
News Placeholder
Inovio (INO) Upgraded to Buy: Here's Why
Inovio (INO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks·1mo ago
News Placeholder
Inovio Pharmaceuticals (NASDAQ:INO) Announces Quarterly Earnings Results, Beats Expectations By $0.07 EPS
Inovio Pharmaceuticals (NASDAQ:INO - Get Free Report) posted its earnings results on Monday. The biopharmaceutical company reported ($0.44) EPS for the quarter, topping the consensus estimate of...
MarketBeat·1mo ago
News Placeholder
INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights
INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights PR Newswire PLYMOUTH MEETING...
PR Newswire·1mo ago
News Placeholder
INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025
INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025 INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025 PR Newswire PLYMOUTH MEETING, Pa., Oct. 27, 2025...
PR Newswire·2mo ago
News Placeholder
INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference
INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference PR Newswire PLYMOUTH MEETING...
PR Newswire·2mo ago
News Placeholder
Clinical Proof-of-Concept Data for DNA-Encoded Monoclonal Antibodies (DMAbs) Published in Nature Medicine
Clinical Proof-of-Concept Data for DNA-Encoded Monoclonal Antibodies (DMAbs) Published in Nature Medicine Clinical Proof-of-Concept Data for DNA-Encoded Monoclonal Antibodies (DMAbs) Published in...
PR Newswire·2mo ago
News Placeholder
INO Stock Soars as FDA Backs Rolling BLA for Rare Lung Disease Drug
Inovio stock surges 21% after the FDA gives green light to begin a rolling BLA for its RRP drug INO-3107, with plans to seek priority review.
Zacks·4mo ago
News Placeholder
PGEN Stock Surges 144% in August on FDA Nod for Rare Lung Disease Drug
Precigen stock soars 144% in August after FDA approval of Papzimeos, the first treatment for adults with recurrent respiratory papillomatosis.
Zacks·4mo ago
<
1
2
...
>

Latest INO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.